Completed PHASE4 INTERVENTIONAL 1-arm NCT04742816

Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients

Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients Sub-Study

Sponsor: University of California, San Diego

Conditions Hormone Replacement Therapy Renal Function Transgender

Interventions IHX-CL measurements Iohexol

Updated 4 times since 2021 Last updated: Mar 1, 2022 Started: Sep 17, 2020 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04742816, this PHASE4 trial focuses on Hormone Replacement Therapy and Renal Function and remains completed. Sponsored by University of California, San Diego, it has been updated 4 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Apr 2022 — Jul 2024 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Mar 2021 — Apr 2022 [monthly]

Recruiting PHASE4

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, San Diego

Data source: University of California, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Diego, United States